BioCardia, Inc.
BCDA
$2.23
-$0.02-0.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.71M | -2.30M | -1.74M | -1.65M | -2.27M |
| Total Depreciation and Amortization | 12.00K | 15.00K | 16.00K | 17.00K | 19.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 267.00K | 271.00K | 269.00K | 239.00K | 267.00K |
| Change in Net Operating Assets | 815.00K | -563.00K | -1.16M | 78.00K | 451.00K |
| Cash from Operations | -1.62M | -2.57M | -2.61M | -1.31M | -1.53M |
| Capital Expenditure | -- | -1.00K | -2.00K | -3.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -1.00K | -2.00K | -3.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 212.00K | 39.00K | 7.20M | 1.85M | 1.47M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -16.00K | -24.00K | -1.08M | -62.00K | -90.00K |
| Cash from Financing | 196.00K | 15.00K | 6.12M | 1.79M | 1.38M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.42M | -2.56M | 3.51M | 472.00K | -154.00K |